Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug

The two companies are the first to launch the product, which is a generic version of Bayer’s Adempas.
More news in Industry
Mphasis extends Social Security Scotland deal in £35.4 million contract
‘Best ever September’: Auto retail sales surge 32% year-on-year
MSMEs seek curbs on steel, metal price surge; urge Centre to cut import duties